Transcode Therapeutics Stock Price on June 7, 2024
| RNAZ Stock | USD 0.34 0.04 9.71% |
If you're considering investing in Transcode Stock, it is important to understand the factors that can impact its price. As of today, the current price of Transcode Therapeutics stands at 0.34, as last reported on the 28th of November, with the highest price reaching 0.38 and the lowest price hitting 0.33 during the day. Transcode Therapeutics is dangerous given 3 months investment horizon. Transcode Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0886, which indicates the firm had a 0.0886% return per unit of risk over the last 3 months. We were able to analyze twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.09% are justified by taking the suggested risk. Use Transcode Therapeutics Semi Deviation of 6.76, risk adjusted performance of 0.0782, and Coefficient Of Variation of 1110.82 to evaluate company specific risk that cannot be diversified away.
At this time, Transcode Therapeutics' Other Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 188 K in 2024, whereas Common Stock is likely to drop 59.85 in 2024. . At this time, Transcode Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.0007 in 2024, whereas Price Earnings Ratio is likely to drop (0.07) in 2024. Transcode Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Transcode |
Sharpe Ratio = 0.0886
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RNAZ | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.36 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.09 actual daily | 21 79% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Transcode Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Transcode Therapeutics by adding it to a well-diversified portfolio.
Price Book 3.9398 | Book Value 2.615 | Enterprise Value 4.8 M | Enterprise Value Ebitda (0.59) | Shares Float 17.3 M |
Transcode Therapeutics Main Headline on 7th of June 2024
Acquisition by Robert Dudley of 135000 shares of Transcode T... by Robert Dudley
Filed transaction by Transcode Therapeutics Director, 10 Percent Owner, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Transcode Therapeutics Valuation on June 7, 2024
It is possible to determine the worth of Transcode Therapeutics on a given historical date. On June 7, 2024 Transcode was worth 1.35 at the beginning of the trading date compared to the closed value of 1.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Transcode Therapeutics stock. Still, in general, we apply an absolute valuation method to find Transcode Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Transcode Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Transcode Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.17 | 1.35 | 1.15 | 1.34 | 489,771 | |
06/07/2024 | 1.35 | 1.35 | 1.06 | 1.10 | 574,027 |
| 1.36 | 1.39 | 1.21 | 1.29 | 909,134 |
| Backtest Transcode Therapeutics | | | Transcode Therapeutics History | | | Transcode Therapeutics Valuation | Previous | Next |
Transcode Therapeutics Trading Date Momentum on June 7, 2024
| On June 10 2024 Transcode Therapeutics was traded for 1.29 at the closing time. The top price for the day was 1.39 and the lowest listed price was 1.21 . The trading volume for the day was 909.1 K. The trading history from June 10, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 17.27% . The trading price change against the current closing price is 5.45% . |
Transcode Therapeutics Fundamentals Correlations and Trends
By evaluating Transcode Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Transcode Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Transcode financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Transcode Therapeutics Stock history
Transcode Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Transcode is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Transcode Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Transcode Therapeutics stock prices may prove useful in developing a viable investing in Transcode Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 179 K | 188 K | |
| Net Loss | -15.8 M | -15 M |
Transcode Therapeutics Stock Technical Analysis
Transcode Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Transcode Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Transcode Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Transcode Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Transcode Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Transcode Therapeutics shares will generate the highest return on investment. By undertsting and applying Transcode Therapeutics stock market strength indicators, traders can identify Transcode Therapeutics entry and exit signals to maximize returns
Transcode Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Transcode Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Transcode Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Transcode to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0782 | |||
| Jensen Alpha | 1.29 | |||
| Total Risk Alpha | (0.82) | |||
| Sortino Ratio | 0.1214 | |||
| Treynor Ratio | (0.60) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Transcode Stock Analysis
When running Transcode Therapeutics' price analysis, check to measure Transcode Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transcode Therapeutics is operating at the current time. Most of Transcode Therapeutics' value examination focuses on studying past and present price action to predict the probability of Transcode Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transcode Therapeutics' price. Additionally, you may evaluate how the addition of Transcode Therapeutics to your portfolios can decrease your overall portfolio volatility.